TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
643,462
|
533,125
|
479,946 |
Financial expenses |
15,031
|
27,038
|
16,409 |
Earnings before taxes |
28,022
|
32,285
|
12,185 |
EBITDA |
82,745
|
95,536
|
53,824 |
Total assets |
1,706,909
|
1,342,796
|
2,269,605 |
Current assets |
700,579
|
363,339
|
1,252,368 |
Current liabilities |
458,604
|
201,164
|
1,118,356 |
Equity capital |
1,231,486
|
1,128,983
|
1,138,132 |
- share capital |
321,319
|
300,030
|
309,327 |
Employees (average) |
345
|
364
|
350 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.1%
|
84.1%
|
50.1% |
Turnover per employee |
1,865
|
1,465
|
1,371 |
Profit as a percentage of turnover |
4.4%
|
6.1%
|
2.5% |
Return on assets (ROA) |
2.5%
|
4.4%
|
1.3% |
Current ratio |
152.8%
|
180.6%
|
112.0% |
Return on equity (ROE) |
2.3%
|
2.9%
|
1.1% |
Change turnover |
72,508
|
67,603
|
129,677 |
Change turnover % |
13%
|
15%
|
37% |
Chg. No. of employees |
-19
|
14
|
54 |
Chg. No. of employees % |
-5%
|
4%
|
18% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.